host picture

| Bookmark and Share

Extending drug patents

Drug makers receive patents that give them the exclusive right to market new drugs but an editorial published in the Canadian Medical Association Journal says evergreening does patients and drug companies more harm than good. Guest host Frank Rackow talks to Dr. Brian Goldman.

Download Flash Player to view this content.
Comments are closed.